Dr. Rosenstein is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1468 Madison Ave
New York, NY 10029
Education & Training
- Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalInternship, Internal Medicine, 2022 - 2025
- Rutgers New Jersey Medical SchoolClass of 2022
Publications & Presentations
PubMed
- 86 citationsUlcerative colitis is characterized by a plasmablast-skewed humoral response associated with disease activity.Mathieu Uzzan, Jerome C Martin, Luka Mesin, Alexandra E Livanos, Tomas Castro-Dopico
Nature Medicine. 2022-04-01 - 8 citationsiTRAQ-based pharmacoproteomics reveals potential targets of berberine, a promising therapy for ulcerative colitis.Yan-hong Li, Wei Sun, Bao-jin Zhou, Adam K. Rosenstein, Jie Zhao
European Journal of Pharmacology. 2019-05-05 - 13 citationsEfficient long-term depletion of CD20+ B cells by rituximab does not affect gut-resident plasma cells.Mathieu Uzzan, Huaibin M. Ko, Adam K. Rosenstein, Kamron Pourmand, Jean-Frederic Colombel
Annals of the New York Academy of Sciences. 2018-03-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: